These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12205783)

  • 41. In vitro activity of cycloSal-nucleoside monophosphates and polyhydroxycarboxylates against orthopoxviruses.
    Sauerbrei A; Meier C; Meerbach A; Schiel M; Helbig B; Wutzler P
    Antiviral Res; 2005 Sep; 67(3):147-54. PubMed ID: 16076502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of interferon in mouse cells infected with MuLV.
    Pitha PM
    Ann N Y Acad Sci; 1980; 350():301-13. PubMed ID: 6165284
    [No Abstract]   [Full Text] [Related]  

  • 43. Influence of interferon on the replication of oncogenic herpesviruses in tissue cultures and in nonhuman primates.
    Laufs R; Steinke H; Jacobs C; Hilfenhaus J; Karges H
    Med Microbiol Immunol; 1974; 160(4):285-94. PubMed ID: 4449516
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of interferons in the control of HIV replication in macrophages.
    Kornbluth RS; Oh PS; Munis JR; Cleveland PH; Richman DD
    Clin Immunol Immunopathol; 1990 Feb; 54(2):200-19. PubMed ID: 1688522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Study of the interferon-inducing activity of various newly synthesized compounds of the hydroxypyrimidine group in cell culture].
    Serkedzhieva Iu; Gagov I; Georgiev G
    Acta Microbiol Virol Immunol (Sofiia); 1975; 2():77-82. PubMed ID: 1240723
    [No Abstract]   [Full Text] [Related]  

  • 46. Selective inhibition of glycoprotein and membrane protein of vesicular stomatitis virus from interferon-treated cells.
    Maheshwari RK; Jay FT; Friedman RM
    Science; 1980 Feb; 207(4430):540-1. PubMed ID: 6243416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interferon and cell division. IX. Interferon-resistant L1210 cells: characteristics and origin.
    Gresser I; Bandu MT; Brouty-Boyé D
    J Natl Cancer Inst; 1974 Feb; 52(2):553-9. PubMed ID: 4856157
    [No Abstract]   [Full Text] [Related]  

  • 48. [Proof of the necessity of antiviral protein synthesis in the presence of interferon action].
    Ershov FI; Tazulakhova EB
    Vopr Virusol; 1976; (3):273-6. PubMed ID: 982995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of interferon-induced transfer of viral resistance against murine leukemia virus or poliovirus in cocultivated cells.
    Mozes LW
    Virology; 1982 Jan; 116(1):359-62. PubMed ID: 6175074
    [No Abstract]   [Full Text] [Related]  

  • 50. [The antiviral properties of Corynebacterium parvum].
    Cerutti I
    C R Acad Hebd Seances Acad Sci D; 1974 Sep; 279(11):963-6. PubMed ID: 4376977
    [No Abstract]   [Full Text] [Related]  

  • 51. Characterization of the interferon-induced double-stranded RNA-dependent protein kinase and its possible role in the antiviral action of interferon.
    Samuel CE
    Prog Clin Biol Res; 1985; 202():247-54. PubMed ID: 2421305
    [No Abstract]   [Full Text] [Related]  

  • 52. Possible role of the Friend virus life cycle in differentiating Friend leukemia cells treated with interferon.
    Dolei A; Capobianchi MR; Cioé L; Colletta G; Vecchio G; Rossi GB; Affabris E; Belardelli F
    Haematol Blood Transfus; 1979; 23():307-11. PubMed ID: 94575
    [No Abstract]   [Full Text] [Related]  

  • 53. Antiviral activity of bovine interferons on primate cells.
    Tovey MG; Bandu MT; Begon-Lours J; Brouty-Boyé D; Gresser I
    J Gen Virol; 1977 Aug; 36(2):341-4. PubMed ID: 197203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [What purpose does interferon serve?].
    Jasmin C
    Presse Med (1893); 1971 Jun; 79(30):1373-5. PubMed ID: 5093009
    [No Abstract]   [Full Text] [Related]  

  • 55. Intracellular events in interferon-treated cells.
    Hovanessian AG
    Differentiation; 1979; 15(3):139-51. PubMed ID: 393560
    [No Abstract]   [Full Text] [Related]  

  • 56. The 2-5A system in control and interferon-treated K/BALB cells infected with encephalomyocarditis virus.
    Meurs E; Krause D; Robert N; Silverman RH; Hovanessian AG
    Prog Clin Biol Res; 1985; 202():307-15. PubMed ID: 2421309
    [No Abstract]   [Full Text] [Related]  

  • 57. Studies on the capacity of human tonsillar lymphocyte subpopulations to produce interferon.
    Sugiyama M; Yamamoto K; Kinoshita Y; Kimura S
    Acta Otolaryngol; 1977; 84(3-4):296-305. PubMed ID: 906822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rat interferons. III. Antiviral activity and effect of "priming" on interferon production in homologous and heterologous cell lines.
    Lobodzińska M; Biernacka I; Skurska Z
    Arch Immunol Ther Exp (Warsz); 1975; 23(2):225-31. PubMed ID: 238487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional and ultrastructural studies of the effects of human interferon on cell membranes of in vitro cultured cells.
    Degré M; Hovig T
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):347-58. PubMed ID: 187008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of interferon on systemic herpesvirus infections.
    Kern ER; Glasgow LA
    Tex Rep Biol Med; 1977; 35():472-7. PubMed ID: 358468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.